Lanean...
Genotypic resistance testing of HCV – is there a clinical need?
Persistent infections with the hepatitis C virus (HCV) pose a profound global public health burden. In the past 5 years treatment of chronic hepatitis C has dramatically changed. Novel direct-acting antivirals (DAAs) specifically inhibiting viral enzymes or factors that are essential for the viral r...
Gorde:
| Argitaratua izan da: | GMS Infect Dis |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
German Medical Science GMS Publishing House
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301723/ https://ncbi.nlm.nih.gov/pubmed/30671319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3205/id000023 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|